Skip to main content

Repeat Preeclampsia Testing Not Tied to Better Perinatal Outcomes

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 27, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Feb. 27, 2024 -- Repeat placental growth factor (PlGF) testing in pregnant women with suspected preeclampsia is not associated with improved perinatal outcomes, according to a study published online Feb. 8 in The Lancet.

Alice Hurrell, from King's College London, and colleagues assessed whether repeat PlGF-based testing reduces adverse perinatal outcomes in pregnant individuals with suspected preterm preeclampsia. The analysis included 1,253 women with suspected preeclampsia (between 22 weeks and 0 days of gestation and 35 weeks and 6 days of gestation).

The researchers found no significant difference in the primary perinatal composite outcome (stillbirth, early neonatal death, or neonatal unit admission) between revealed repeat PlGF-based testing (31.2 percent) versus concealed repeat PlGF-based testing with usual care (27.8 percent; relative risk, 1.21; 95 percent confidence interval, 0.95 to 1.33). There were four serious adverse events in the revealed repeat PlGF-based testing group and six in the concealed repeat PlGF-based testing group, all deemed unrelated to the intervention.

"In a high-income setting with a low prevalence of adverse outcomes, universal, routine repeat PlGF-based testing of all individuals with suspected pre-eclampsia is not recommended," the authors write.

One author disclosed ties to Revvity, QuidelOrtho, and Roche.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults

FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...

Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income

FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...

Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women

FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.